Concettina La Motta

4.5k total citations
138 papers, 3.7k citations indexed

About

Concettina La Motta is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Concettina La Motta has authored 138 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 54 papers in Organic Chemistry and 32 papers in Cell Biology. Recurrent topics in Concettina La Motta's work include Aldose Reductase and Taurine (32 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Synthesis and biological activity (15 papers). Concettina La Motta is often cited by papers focused on Aldose Reductase and Taurine (32 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Synthesis and biological activity (15 papers). Concettina La Motta collaborates with scholars based in Italy, United States and Germany. Concettina La Motta's co-authors include Federico Da Settimo, Stefania Sartini, Ettore Novellino, Sabrina Taliani, Francesca Simorini, Anna María Marini, Silvia Salerno, Luca Quattrini, Giampaolo Primofiore and Luciana Marinelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Concettina La Motta

133 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Concettina La Motta Italy 36 1.5k 1.3k 595 547 420 138 3.7k
Matthias U. Kassack Germany 48 2.9k 1.9× 1.1k 0.9× 991 1.7× 237 0.4× 278 0.7× 153 5.5k
George Kokotos Greece 40 3.1k 2.0× 1.9k 1.5× 242 0.4× 407 0.7× 297 0.7× 197 5.4k
Michael R. Jirousek United States 29 2.8k 1.8× 606 0.5× 393 0.7× 165 0.3× 348 0.8× 60 4.7k
Donald Poirier Canada 40 2.6k 1.7× 1.3k 1.0× 725 1.2× 335 0.6× 2.0k 4.8× 248 5.9k
Hidehiko Nakagawa Japan 40 2.4k 1.5× 1.2k 0.9× 498 0.8× 163 0.3× 219 0.5× 170 4.9k
Anthony B. Pinkerton United States 36 1.3k 0.8× 1.5k 1.2× 298 0.5× 120 0.2× 278 0.7× 99 3.8k
Jih‐Hwa Guh Taiwan 40 2.7k 1.8× 1.0k 0.8× 611 1.0× 262 0.5× 220 0.5× 177 4.8k
Marco Macchia Italy 36 2.1k 1.4× 1.2k 0.9× 341 0.6× 111 0.2× 194 0.5× 226 4.3k
Bhaskar C. Das United States 32 1.4k 0.9× 798 0.6× 322 0.5× 181 0.3× 125 0.3× 111 3.4k
Hongguang Xia China 34 1.5k 1.0× 1.4k 1.1× 343 0.6× 327 0.6× 54 0.1× 76 3.8k

Countries citing papers authored by Concettina La Motta

Since Specialization
Citations

This map shows the geographic impact of Concettina La Motta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concettina La Motta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concettina La Motta more than expected).

Fields of papers citing papers by Concettina La Motta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concettina La Motta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concettina La Motta. The network helps show where Concettina La Motta may publish in the future.

Co-authorship network of co-authors of Concettina La Motta

This figure shows the co-authorship network connecting the top 25 collaborators of Concettina La Motta. A scholar is included among the top collaborators of Concettina La Motta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concettina La Motta. Concettina La Motta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piano, Ilaria, Beatrice Polini, Sara Carpi, et al.. (2025). β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study. European Journal of Pharmaceutics and Biopharmaceutics. 208. 114660–114660.
2.
Motta, Concettina La, et al.. (2025). Polyvinyl chloride (PVC), its additives, microplastic and human health: Unresolved and emerging issues. The Science of The Total Environment. 960. 178276–178276. 16 indexed citations
3.
Motta, Concettina La, et al.. (2024). Helicobacter pylori CAs inhibition. ˜The œEnzymes. 55. 213–241. 3 indexed citations
4.
Ferrari, Silvia Martina, Giusy Elia, Francesca Ragusa, et al.. (2023). Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture. International Journal of Molecular Sciences. 24(3). 2398–2398. 5 indexed citations
5.
Fallarini, Silvia, Silvio Aprile, Valentina Audrito, et al.. (2023). A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment. International Journal of Molecular Sciences. 24(7). 6689–6689. 4 indexed citations
6.
Ciccone, Lidia, Caterina Camodeca, Nicolò Tonali, et al.. (2023). New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer’s Disease. Pharmaceutics. 15(10). 2369–2369. 2 indexed citations
7.
Colombo, Giorgia, Davide M. Ferraris, Eleonora Aronica, et al.. (2021). A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro. Cancers. 13(2). 356–356. 33 indexed citations
8.
D’Andrea, Felicia, Stefania Sartini, Ilaria Piano, et al.. (2020). Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1194–1205. 7 indexed citations
9.
Yamashita, Daisuke, Mutsuko Minata, Shinobu Yamaguchi, et al.. (2020). Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells. Molecular Cancer Therapeutics. 19(5). 1134–1147. 27 indexed citations
10.
Brogi, Simone, Marco Paolino, Angela Di Capua, et al.. (2019). Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold. Bioorganic & Medicinal Chemistry. 27(19). 115045–115045. 25 indexed citations
11.
Salerno, Silvia, Aída Nelly García‐Argáez, Elisabetta Barresi, et al.. (2018). New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors. European Journal of Medicinal Chemistry. 150. 446–456. 8 indexed citations
12.
Cheng, Peng, Jia Wang, Indrayani Waghmare, et al.. (2016). FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells. Cancer Research. 76(24). 7219–7230. 117 indexed citations
13.
Barresi, Elisabetta, Sabrina Taliani, Sandro Cosconati, et al.. (2015). Deepening the Topology of the Translocator Protein Binding Site by NovelN,N-Dialkyl-2-arylindol-3-ylglyoxylamides. Journal of Medicinal Chemistry. 58(15). 6081–6092. 35 indexed citations
14.
Cosimelli, Barbara, Francesca Simorini, Sabrina Taliani, et al.. (2011). Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein. European Journal of Medicinal Chemistry. 46(9). 4506–4520. 15 indexed citations
15.
Pietra, Valeria La, Luciana Marinelli, Sandro Cosconati, et al.. (2011). Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: A first round of lead optimization. European Journal of Medicinal Chemistry. 47(1). 143–152. 24 indexed citations
16.
Cosimelli, Barbara, Giovanni Greco, Ettore Novellino, et al.. (2008). Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 51(6). 1764–1770. 49 indexed citations
17.
Zentgraf, Matthias, H. Steuber, C. Koch, et al.. (2007). How Reliable Are Current Docking Approaches for Structure‐Based Drug Design? Lessons from Aldose Reductase. Angewandte Chemie International Edition. 46(19). 3575–3578. 54 indexed citations
18.
SETTIMO, A. DA, Giampaolo Primofiore, Federico Da Settimo, et al.. (2000). Synthesis of a novel purine‐containing heterocyclic ring system: 8,10‐Dimethylindolo[2′,3′:5,6][1,2,4]triazino[4,3‐f]purine‐9,11(8H, 10H, 13H)‐dione. Journal of Heterocyclic Chemistry. 37(2). 373–377.
19.
SETTIMO, A. DA, Giampaolo Primofiore, Concettina La Motta, et al.. (1996). Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.. PubMed. 51(4). 261–7. 7 indexed citations
20.
SETTIMO, A. DA, Giampaolo Primofiore, Federico Da Settimo, et al.. (1996). Synthesis of pyrrolo[3,4-c]pyridine derivatives possessing an acid group and their in vitro and in vivo evaluation as aldose reductase inhibitors. European Journal of Medicinal Chemistry. 31(1). 49–58. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026